100 related articles for article (PubMed ID: 60146)
1. Is there a relationship between alpha-1-antitrypsin Pi MZ phenotype and hepatoma?
Charlionet R; Martin JP; Sesboué R; Ropartz C
Biomedicine; 1976 Jun; 25(4):125-6. PubMed ID: 60146
[No Abstract] [Full Text] [Related]
2. Alpha 1-antitrypsin phenotypes in cirrhosis and hepatoma.
Theodoropoulos G; Fertakis A; Archimandritis A; Kapordelis C; Angelopoulos B
Acta Hepatogastroenterol (Stuttg); 1976 Apr; 23(2):114-7. PubMed ID: 179260
[TBL] [Abstract][Full Text] [Related]
3. Emphysema, cirrhosis, and hepatoma with alpha-1 antitrypsin deficiency.
Lieberman J
Ann Intern Med; 1974 Dec; 81(6):850-2. PubMed ID: 4372921
[No Abstract] [Full Text] [Related]
4. Alpha-1-antitrypsin deficiency and liver diseases in Nigeria.
Olusi SO
Trop Geogr Med; 1990 Jan; 42(1):41-6. PubMed ID: 2175465
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ).
Rawlings W; Moss J; Cooper HS; Hamilton SR
Ann Intern Med; 1974 Dec; 81(6):771-3. PubMed ID: 4372920
[No Abstract] [Full Text] [Related]
6. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
Niermeijer P; Gips CH; Marrink J; QUE GS
Neth J Med; 1976; 19(1):25-8. PubMed ID: 55985
[No Abstract] [Full Text] [Related]
7. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
Niermeijer P; Gips CH; Marrink J; Qué GS
Neth J Med; 1976; 19(1):15-8. PubMed ID: 55984
[No Abstract] [Full Text] [Related]
8. [Serum concentrations of alpha-1-fetoprotein suggestive of, or pathognomonic for hepatoma (author's transl)].
Polterauer P; Horak W; Legenstein E; Müller M
Wien Klin Wochenschr; 1979 Mar; 91(6):201-4. PubMed ID: 85372
[TBL] [Abstract][Full Text] [Related]
9. [Alpha 1-antitrypsin deficiency and the liver (author's transl)].
Spech HJ; Liehr H
Z Gastroenterol; 1982 Jul; 20(7):393-404. PubMed ID: 6287750
[TBL] [Abstract][Full Text] [Related]
10. [Hepatocellular carcinoma and the alpha 1-antitrypsin phenotype].
Labadie H; Sesboué R; Martin JP; Beaugrand M
Gastroenterol Clin Biol; 1985 Dec; 9(12):881-5. PubMed ID: 3007258
[TBL] [Abstract][Full Text] [Related]
11. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma.
Rabinovitz M; Gavaler JS; Kelly RH; Prieto M; Van Thiel DH
Hepatology; 1992 Mar; 15(3):407-10. PubMed ID: 1312055
[TBL] [Abstract][Full Text] [Related]
12. [Role of alpha 1-antitrypsin and alpha-2 macroglobulin in hepatopathies].
Triolo L; Mian G; Magris D; Novello E; D'Agnolo B
Minerva Med; 1979 Feb; 70(8):605-10. PubMed ID: 86175
[TBL] [Abstract][Full Text] [Related]
13. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
[TBL] [Abstract][Full Text] [Related]
14. [Primary liver cell carcinoma as complication of alpha 1-antitrypsin deficiency in a 67 year old man].
van den Hazel SJ; Meijer JW; van den Elshout FJ; de Vries RA
Ned Tijdschr Geneeskd; 2000 Nov; 144(47):2269-72. PubMed ID: 11109473
[TBL] [Abstract][Full Text] [Related]
15. Alpha1-fetoprotein in liver disease in Sarawak.
Kothare SN
Singapore Med J; 1978 Dec; 19(4):220-4. PubMed ID: 87015
[No Abstract] [Full Text] [Related]
16. Non-specific tumoral markers in hepatocellular carcinoma.
Stanciu L; Dumitraşcu D; Radu D; Badea R
Med Interne; 1990; 28(2):139-44. PubMed ID: 1702896
[TBL] [Abstract][Full Text] [Related]
17. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
[No Abstract] [Full Text] [Related]
18. Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype).
Lieberman J; Silton RM; Agliozzo CM; McMahon J
Am J Clin Pathol; 1975 Sep; 64(3):304-10. PubMed ID: 169686
[TBL] [Abstract][Full Text] [Related]
19. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
Smanadhikorn P; Pongpaew P; Srivatanakul P; Tungtrongchitr R; Supanaranond W; Schelp FP; Migasena P
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):240-2. PubMed ID: 8629052
[TBL] [Abstract][Full Text] [Related]
20. [Liver and hereditary alpha 1-antitrypsin deficiency].
Feldmann G
Gastroenterol Clin Biol; 1993; 17(2):83-93. PubMed ID: 8388836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
